LEXX 8-K 2026-09-01

Lexaria Bioscience Corp. (LEXX) 8-K dated 2026-09-01 — accession 0001640334-26-001437.

Lexaria Bioscience Corp. (LEXX) is a biotechnology company listed on US.

Lexaria Bioscience Corp. filed a 8-K on 2026-09-01. Accession 0001640334-26-001437.

This 8-K covers: Other events (Item 8.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported LEXX revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXX currently screens at market cap $14.9M.

Not investment advice. The LEXX SEC hub lists recent forms. The stock page is the research view.